Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Fragile X Syndrome – Overview
Fragile X Syndrome – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Fragile X Syndrome – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Fragile X Syndrome – Companies Involved in Therapeutics Development
Fragile X Syndrome – Drug Profiles
Fragile X Syndrome – Dormant Projects
Fragile X Syndrome – Discontinued Products
Fragile X Syndrome – Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Fragile X Syndrome, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Fragile X Syndrome, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Fragile X Syndrome – Pipeline by Actinogen Medical Ltd, 2022
Fragile X Syndrome – Pipeline by Allos Pharma Inc, 2022
Fragile X Syndrome – Pipeline by Anavex Life Sciences Corp, 2022
Fragile X Syndrome – Pipeline by Anima Biotech Inc, 2022
Fragile X Syndrome – Pipeline by Astellas Pharma Inc, 2022
Fragile X Syndrome – Pipeline by Autifony Therapeutics Ltd, 2022
Fragile X Syndrome – Pipeline by Avekshan LLC, 2022
Fragile X Syndrome – Pipeline by Cognosetta Inc, 2022
Fragile X Syndrome – Pipeline by Confluence Pharmaceuticals LLC, 2022
Fragile X Syndrome – Pipeline by Connecta Therapeutics SL, 2022
Fragile X Syndrome – Pipeline by DRI Biosciences Corp, 2022
Fragile X Syndrome – Pipeline by Epigen Biosciences Inc, 2022
Fragile X Syndrome – Pipeline by GEXVal Inc, 2022
Fragile X Syndrome – Pipeline by GSK plc, 2022
Fragile X Syndrome – Pipeline by Healx Ltd, 2022
Fragile X Syndrome – Pipeline by Hua Medicine Shanghai Ltd, 2022
Fragile X Syndrome – Pipeline by Jazz Pharmaceuticals Plc, 2022
Fragile X Syndrome – Pipeline by Lysogene SAS, 2022
Fragile X Syndrome – Pipeline by Neuren Pharmaceuticals Ltd, 2022
Fragile X Syndrome – Pipeline by Neurochlore, 2022
Fragile X Syndrome – Pipeline by NeuroNascent Inc, 2022
Fragile X Syndrome – Pipeline by Novartis AG, 2022
Fragile X Syndrome – Pipeline by Paxmedica Inc, 2022
Fragile X Syndrome – Pipeline by Pilz Bioscience Corp, 2022
Fragile X Syndrome – Pipeline by Prilenia Therapeutics Development Ltd, 2022
Fragile X Syndrome – Pipeline by Prous Institute for Biomedical Research SA, 2022
Fragile X Syndrome – Pipeline by Puretech Health Plc, 2022
Fragile X Syndrome – Pipeline by Quris Technologies Ltd, 2022
Fragile X Syndrome – Pipeline by Recursion Pharmaceuticals Inc, 2022
Fragile X Syndrome – Pipeline by RespireRx Pharmaceuticals Inc, 2022
Fragile X Syndrome – Pipeline by Sentinel Oncology Ltd, 2022
Fragile X Syndrome – Pipeline by Synaptogenix Inc, 2022
Fragile X Syndrome – Pipeline by Takeda Pharmaceutical Co Ltd, 2022
Fragile X Syndrome – Pipeline by Taysha Gene Therapies Inc, 2022
Fragile X Syndrome – Pipeline by Tetra Therapeutics, 2022
Fragile X Syndrome – Pipeline by Triplet Therapeutics Inc, 2022
Fragile X Syndrome – Pipeline by Zynerba Pharmaceuticals Inc, 2022
Fragile X Syndrome – Dormant Projects, 2022
Fragile X Syndrome – Dormant Projects, 2022 (Contd..1)
Fragile X Syndrome – Discontinued Products, 2022